| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.22 | 1e-08 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-06 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-06 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-06 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.19 | 6e-06 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.17 | 7e-06 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.19 | 8e-06 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.16 | 8e-06 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.19 | 9e-06 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |